Janus Henderson Group
BIVV

Janus Henderson Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Janus Henderson Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,457,583
Closed -$78.6M – 1416
2017
Q4 		$78.6M Buy
1,457,583
+406,132
+39% +$22.2M 0.05% 423
2017
Q3 		$60M Buy
1,051,451
+321,136
+44% +$18.8M 0.04% 475
2017
Q2 		$43.9M Buy
730,315
+725,938
+16,585% +$41.3M 0.03% 551
2017
Q1 		$238K Buy
+4,377
New +$216K ﹤0.01% 817

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Janus Henderson Group's BIVV Position: Q1 2018 in Review

Janus Henderson Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,457,583 shares — an estimated $78.6M sold.

Janus Henderson Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $78.6M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Janus Henderson Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Janus Henderson Group sold 1,457,583 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $78.6M.
  • Janus Henderson Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Janus Henderson Group's Bioverativ Inc. Common Stock position peaked at $78.6M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Janus Henderson Group's 13F filing for Q1 2018, filed 14 May 2018.